However, they have significant differences between them, such as: Key Differences Benefits of Injectable Medications Parenteral medications (subcutaneous, intramuscular, intravenous injections) have several clinical advantages
However, sermorelin is preferred over recombinant growth hormone as it causes fewer side effects
Growing evidence suggest that the elevation of GLP-1 is also critically involved in the effects of metformin, gut microbiota, and bariatric surgery on metabolic homeostasis 3,4,5,6
[83] Society and culture [edit] Legal status [edit] In December 2016, a new drug application was filed with the US Food and Drug Administration (FDA), and in October 2017, an FDA advisory committee approved it unanimously